These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 8752936)

  • 21. Apoptosis of a human melanoma cell line specifically induced by membrane-bound single-chain antibodies.
    de Inés C; Cochlovius B; Schmidt S; Kipriyanov S; Rode HJ; Little M
    J Immunol; 1999 Oct; 163(7):3948-56. PubMed ID: 10490996
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Creating CTL targets with epitope-linked beta 2-microglobulin constructs.
    Uger RA; Barber BH
    J Immunol; 1998 Feb; 160(4):1598-605. PubMed ID: 9469415
    [TBL] [Abstract][Full Text] [Related]  

  • 23. TCR gamma delta cytotoxic T lymphocytes expressing the killer cell-inhibitory receptor p58.2 (CD158b) selectively lyse acute myeloid leukemia cells.
    Dolstra H; Fredrix H; van der Meer A; de Witte T; Figdor C; van de Wiel-van Kemenade E
    Bone Marrow Transplant; 2001 May; 27(10):1087-93. PubMed ID: 11438826
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Superior antitumor in vitro responses of allogeneic matched sibling compared with autologous patient CD8+ T cells.
    Kausche S; Wehler T; Schnürer E; Lennerz V; Brenner W; Melchior S; Gröne M; Nonn M; Strand S; Meyer R; Ranieri E; Huber C; Falk CS; Herr W
    Cancer Res; 2006 Dec; 66(23):11447-54. PubMed ID: 17145892
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Preservation and redirection of HPV16E7-specific T cell receptors for immunotherapy of cervical cancer.
    Scholten KB; Schreurs MW; Ruizendaal JJ; Kueter EW; Kramer D; Veenbergen S; Meijer CJ; Hooijberg E
    Clin Immunol; 2005 Feb; 114(2):119-29. PubMed ID: 15639645
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Engineered CD20-specific primary human cytotoxic T lymphocytes for targeting B-cell malignancy.
    Jensen MC; Cooper LJ; Wu AM; Forman SJ; Raubitschek A
    Cytotherapy; 2003; 5(2):131-8. PubMed ID: 12745575
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A phage display selected fab fragment with MHC class I-restricted specificity for MAGE-A1 allows for retargeting of primary human T lymphocytes.
    Willemsen RA; Debets R; Hart E; Hoogenboom HR; Bolhuis RL; Chames P
    Gene Ther; 2001 Nov; 8(21):1601-8. PubMed ID: 11894998
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The systemic administration of Ig-4-1BB ligand in combination with IL-12 gene transfer eradicates hepatic colon carcinoma.
    Xu DP; Sauter BV; Huang TG; Meseck M; Woo SL; Chen SH
    Gene Ther; 2005 Oct; 12(20):1526-33. PubMed ID: 15973445
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Redirecting human CD4+ T lymphocytes to the MHC class I-restricted melanoma antigen MAGE-A1 by TCR alphabeta gene transfer requires CD8alpha.
    Willemsen R; Ronteltap C; Heuveling M; Debets R; Bolhuis R
    Gene Ther; 2005 Jan; 12(2):140-6. PubMed ID: 15496961
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification of a human CD8+ T lymphocyte neo-epitope created by a ras codon 12 mutation which is restricted by the HLA-A2 allele.
    Bergmann-Leitner ES; Kantor JA; Shupert WL; Schlom J; Abrams SI
    Cell Immunol; 1998 Aug; 187(2):103-16. PubMed ID: 9732698
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Induction of G250-targeted and T-cell-mediated antitumor activity against renal cell carcinoma using a chimeric fusion protein consisting of G250 and granulocyte/monocyte-colony stimulating factor.
    Tso CL; Zisman A; Pantuck A; Calilliw R; Hernandez JM; Paik S; Nguyen D; Gitlitz B; Shintaku PI; de Kernion J; Figlin R; Belldegrun A
    Cancer Res; 2001 Nov; 61(21):7925-33. PubMed ID: 11691814
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficient tumor cell lysis mediated by a bispecific single chain antibody expressed in Escherichia coli.
    Gruber M; Schodin BA; Wilson ER; Kranz DM
    J Immunol; 1994 Jun; 152(11):5368-74. PubMed ID: 8189055
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Redirecting mouse T hybridoma against human breast and ovarian carcinomas: in vivo activity against HER-2/neu expressing cancer cells.
    Gritzapis AD; Mamalaki A; Kretsovali A; Papamatheakis J; Belimezi M; Perez SA; Baxevanis CN; Papamichail M
    Br J Cancer; 2003 Apr; 88(8):1292-300. PubMed ID: 12698199
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Characterization of a chimeric T-cell receptor with specificity for the Hodgkin's lymphoma-associated CD30 antigen.
    Hombach A; Heuser C; Sircar R; Tillmann T; Diehl V; Pohl C; Abken H
    J Immunother; 1999 Nov; 22(6):473-80. PubMed ID: 10570745
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cytotoxic T lymphocytes with a grafted recognition specificity for ERBB2-expressing tumor cells.
    Moritz D; Wels W; Mattern J; Groner B
    Proc Natl Acad Sci U S A; 1994 May; 91(10):4318-22. PubMed ID: 7910405
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Specific targeting of EGP-2+ tumor cells by primary lymphocytes modified with chimeric T cell receptors.
    Ren-Heidenreich L; Hayman GT; Trevor KT
    Hum Gene Ther; 2000 Jan; 11(1):9-19. PubMed ID: 10646635
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lysis of ovarian cancer cells by human lymphocytes redirected with a chimeric gene composed of an antibody variable region and the Fc receptor gamma chain.
    Hwu P; Shafer GE; Treisman J; Schindler DG; Gross G; Cowherd R; Rosenberg SA; Eshhar Z
    J Exp Med; 1993 Jul; 178(1):361-6. PubMed ID: 8315392
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A single-chain bispecific Fv2 molecule produced in mammalian cells redirects lysis by activated CTL.
    Jost CR; Titus JA; Kurucz I; Segal DM
    Mol Immunol; 1996 Feb; 33(2):211-9. PubMed ID: 8649442
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A rapid and versatile method for harnessing scFv antibody fragments with various biological effector functions.
    Helfrich W; Haisma HJ; Magdolen V; Luther T; Bom VJ; Westra J; van der Hoeven R; Kroesen BJ; Molema G; de Leij L
    J Immunol Methods; 2000 Apr; 237(1-2):131-45. PubMed ID: 10725458
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Retroviral transfer of T-cell receptor genes produces cells with a broad range of lytic activity.
    Orentas RJ; Bircher LA; Roskopf S
    Scand J Immunol; 2003 Jul; 58(1):33-42. PubMed ID: 12828556
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.